Anavex Life Sciences Corp (AVXL)

[Hoskuld]

I don’t have to prove anything to you.

I don't understand why you feel a need to write the above. Apparently, you do feel a need to "prove" something to me...or maybe to the board in general. You can't do it but really want to. Bottom line is that your endless pontifications about your emotions regarding Anavex (like plmr's and others' notes here) are not helpful to anyone - I think you guys just like to imagine that what you are writing is important or thoughtful. It isn't. You guys don't seem to know anything about pre-commercial life sciences, about any of the regulatory processes, about the documentation that is required to support clinical progression, or about the constraints and challenges that a pre-commercial life sciences company faces in several spaces.

I don't know if 2-73 Excellence results will be awesome. I think they will, but I don't know. So far, every trial has gone extremely well. That could change, but I doubt it. IMO, the company will publish their results and file for Rett and AD approval with the FDA. They will keep updating their application for MAA to the EMA. They will start trials for PD and Fragile X and maybe MS and/or ALS and/or Angelmans, 3-71 should start epilepsy trial. They are likely to negotiate a helpful sales/marketing partnership with a large multi-national pharmaceutical company. When the share price rises significantly, I think they will raise money at an attractive share price and fund growth.

The company has $150m in cash and no debt, so they are not going to be subject to strong-arming. We know the AD data is good because EMA has seen it and encouraged filing for marketing authorization. The EMA and TGA make the FDA more of a level playing field. Let's see what happens.